EcoR1 Capital LLC 13D and 13G filings for Mirati Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-12-27 4:05 pm Purchase | 2023-12-18 | 13G | Mirati Therapeutics, Inc. MRTX | EcoR1 Capital LLC | 7,396,979 10.500% | 1,648,580 (+28.68%) | Filing |
| 2023-10-02 4:08 pm Purchase | 2023-09-22 | 13G | Mirati Therapeutics, Inc. MRTX | EcoR1 Capital LLC | 5,748,399 8.500% | 5,748,399 (New Position) | Filing |